Krka DD Novo Mesto operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Krka DD Novo Mesto with three other
pharmaceutical manufacturers in Europe:
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
sales of 365.22 billion Hungarian Forints [US$1.26 billion]
of which 82%
was Pharmaceutical Manufacturing and Sale),
Jazz Pharmaceuticals Plc
(1.20 billion Euro [US$1.28 billion]
of which 100%
was Pharmaceutical Products), and
Croda International Plc
based in the United Kingdom
(£1.08 billion [US$1.32 billion]
of which 35%
was Personal Care).
Krka DD Novo Mesto reported sales of 1.16 billion Euro (US$1.24 billion)
December of 2015.
decrease of 2.3%
versus 2014, when the company's sales were 1.19 billion Euro.
Contributing to the drop in overall sales was the 19.9% decline
in Eastern Europe, from 408.65 million Euro to 327.47 million Euro.
However, these declines were partially offset by the increase in sales of
European Union (up 6.7% to 741.50 million Euro)
South East Europe (up 1.0% to 55.78 million Euro)
Others (up 20.8% to 39.87 million Euro)